| PERIOD ENDING | 2-Aug-08 | 3-May-08 | 2-Feb-08 | 3-Nov-07 | | Total Revenue | 1,646,502 | 1,713,598 | 2,208,110 | 1,674,159 | | Cost of Revenue | 1,129,366 | 1,118,302 | 1,461,224 | 1,070,661 | | | Gross Profit | 517,136 | 595,296 | 746,886 | 603,498 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 493,770 | 496,598 | 568,420 | 534,265 | | Non Recurring | (8,093) | 826 | 15,828 | (7,370) | | Others | 73,021 | 72,075 | 74,089 | 75,043 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (41,562) | 25,797 | 88,549 | 1,560 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 4,119 |
-
| | Earnings Before Interest And Taxes | (41,562) | 25,797 | 92,668 | 1,560 | | Interest Expense | 23,026 | 22,113 | 29,077 | 23,121 | | Income Before Tax | (64,588) | 3,684 | 63,591 | (21,561) | | Income Tax Expense | (27,260) | 1,610 | 11,800 | (6,830) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (38,340) | 2,693 | 47,344 | (11,341) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (38,340) | 2,693 | 47,344 | (11,341) | | Preferred Stock And Other Adjustments | (6,022) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($44,362) | $2,693 | $47,344 | ($11,341) |
|
1.49% Nasdaq 
0.27%
Income Statement
